๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Lack of clinical efficacy of chronic oral physostigmine in Alzheimer's disease

โœ Scribed by Dr. Seymour Jotkowitz

Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
191 KB
Volume
14
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Clinical predictors of aggressive behavi
Clinical predictors of aggressive behaviour in Alzheimer's disease
โœ Niall Gormley; M. R. Rizwan; Simon Lovestone ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 125 KB ๐Ÿ‘ 2 views

## Objectives: To examine the level and clinical correlates of aggressive behaviour in alzheimer's disease (ad). ## Method: Seventy patients with probable ad were rated using validated assessment instruments including the rating scale for aggressive behaviour in the elderly (rage). ## Results:

Analysis of longitudinal data in an Alzh
Analysis of longitudinal data in an Alzheimer's disease clinical trial
โœ Ronald G. Thomas; Julie D. Berg; Mary Sano; Leon Thal ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 128 KB ๐Ÿ‘ 2 views

Evidence of delayed progression is the primary mechanism for demonstrating therapeutic e cacy in clinical trials in Alzheimer's disease. In the major trials of therapeutic treatment of AD, to date, measures based on clinical judgement and cognitive performance, instead of mortality, have been used a

Prevalence and clinical correlates of ps
Prevalence and clinical correlates of psychotic symptoms in Alzheimer's disease
โœ Niall Gormley; Mohammed R. Rizwan ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB ๐Ÿ‘ 2 views

Psychotic symptoms occur commonly in Alzheimer's disease (AD), predict a more rapid rate of cognitive decline and increase the risk of aggressive behaviour. Seventy patients with probable AD, recruited from an old age psychiatry service, were assessed to determine the prevalence and clinical correla